Anaphylaxis & Hypersensitivity Reactions
High-yield Verified · Sep 2026Anaphylaxis is a rapidly evolving, generalized, multi-system allergic reaction — an acute hypersensitivity emergency that can begin within minutes of exposure and quickly become life-threatening.
One page, two payloads: the four Gell–Coombs hypersensitivity types every exam maps, and the type I emergency itself — recognition even without hives, IM epinephrine before anything else, positioning that prevents sudden death, and the biphasic return no one expects.
What’s going wrong in the body
The normal physiology, where it fails, and why the body’s compensation backfires.
01 Four ways the immune system overreacts
Hypersensitivity is a normal immune apparatus aimed at the wrong target, and the Gell–Coombs classification sorts the damage by mechanism. Type I (immediate) is IgE bound to mast cells reacting within minutes to typically harmless environmental antigens — anaphylaxis, allergic asthma, allergic rhinitis, food allergy, urticaria and angioedema. Type II (cytotoxic) is IgG or IgM antibody binding antigens on cell surfaces, destroying the cell through complement (the membrane attack complex), C3b-tagged phagocytosis, or NK-cell killing — the hemolytic transfusion reaction, autoimmune hemolytic anemia, hemolytic disease of the newborn, Goodpasture disease, immune thrombocytopenia.
Type III (immune complex) is circulating antigen–antibody complexes depositing in skin, joints and kidneys, where complement (C3a/C5a) summons neutrophils that injure the tissue — serum sickness (beginning 1–2 weeks after first exposure), lupus nephritis, and post-streptococcal glomerulonephritis. Type IV (delayed) has no antibody at all: sensitized T cells and their cytokines drive inflammation that typically appears 48–72 hours after exposure — contact dermatitis (poison ivy, nickel), the tuberculin (PPD) skin test, granulomatous inflammation, and severe drug reactions like SJS/TEN. The timing is the exam tell: minutes = I, days = IV.
02 The silent setup: sensitization
Anaphylaxis is the classic type I reaction, and it takes two exposures to build. The first exposure causes no symptoms: antigen-presenting cells activate T-helper cells, T-helper cells push B cells to produce allergen-specific IgE, and that IgE docks onto high-affinity FcεRI receptors on mast cells and basophils. The patient walks away sensitized — armed — and has no idea.
On re-exposure, the allergen cross-links the IgE already sitting on mast cells and basophils, and the cells degranulate: histamine, tryptase, carboxypeptidase A and proteoglycans dump out preformed, while leukotrienes, prostaglandins and platelet-activating factor are newly synthesized. This is why the "first dose was fine" history is worthless reassurance — the fine first dose is exactly what loaded the weapon.
03 The mediator storm: three fronts at once
The released mediators attack on parallel fronts, and each maps to a bedside finding. Histamine drives vasodilation and increased vascular permeability → tissue hypoperfusion; prostaglandin D constricts bronchi; leukotrienes and PAF do both — bronchoconstriction plus more capillary leak. The net result is the anaphylaxis triad: vasodilation + capillary leak (hypotension, urticaria, angioedema), bronchospasm (wheeze), and upper-airway swelling — with GI cramping, vomiting and diarrhea riding along. Onset is fast: usually within 1 hour of exposure, often within seconds to minutes.
The circulatory collapse is distributive shock: the vessels dilate and leak until the central vascular compartment is effectively empty. That single mechanism explains two core interventions — lay the patient supine with the legs elevated to keep what volume remains in the central circulation, and give epinephrine, whose alpha-1 vasoconstriction directly reverses the dilation and leak while its beta effects open the bronchi.
04 Why it isn’t over when it’s over
Type I reactions carry a late phase: hours after the initial mediator burst, recruited eosinophils and T cells can make symptoms persist or recur. Clinically this shows up as the biphasic reaction — symptoms return after apparent resolution, without any re-exposure — in up to 20% of cases (clinically significant in 4–5%), peaking 8–11 hours after the initial reaction. This is the entire rationale for the observation window and for warning every discharged patient that "better" is not the same as "done."
The stakes justify the urgency: anaphylaxis has a lifetime prevalence of about 1–3%, causes at least 1,500 US deaths per year, and kills fewer than 0.5% of patients who reach an emergency department or hospital — and half of all fatalities occur within the first hour. With rapid, adequate treatment and monitoring, though, the risk of morbidity and mortality is low. The window is short; the outcome inside it is excellent.
Causes & risk factors
Modifiable factors are teaching targets — the patient can act on them.
Signs & symptoms
Each finding tied to the mechanism that produces it — and the triage it calls for.
Diagnostics
Complications
Medications for this condition
Why each class is prescribed here — every card links to its full pharmacology page.
Epinephrine is THE drug of anaphylaxis — given first, immediately on recognition: its alpha-1 vasoconstriction reverses the vasodilation and capillary leak while its beta effects reverse the bronchospasm. Adult dose 0.3–0.5 mg IM (1 mg/mL) in the mid-anterolateral thigh (pediatric 0.01 mg/kg, max 0.5 mg), repeatable every 5–15 minutes (WAO 2020) — about 35% of patients need a second dose. There is no absolute contraindication in anaphylaxis. Refractory cases escalate to a low-dose IV epinephrine infusion in the ICU.
Adjunct only — never first, never a reason epinephrine waits. H1 (diphenhydramine 25–50 mg IV/IM) plus H2 (famotidine 20 mg IV) relieve the cutaneous and minor allergic symptoms, but their benefit in anaphylaxis itself is unproven, and WAO warns they can delay the intervention that saves lives: repeated IM epinephrine. Giving diphenhydramine first is the classic exam trap.
Adjunct only, and increasingly debated. Methylprednisolone 80–125 mg IV (or hydrocortisone 250–500 mg IV) acutely, then oral prednisone 40–60 mg/day for 3–5 days; StatPearls frames the rationale as reducing the length or biphasic response of anaphylaxis, but WAO 2020 cites increasing evidence of no benefit in acute management — possibly harm — making routine use controversial. Whatever the verdict, a steroid never delays epinephrine.
Beyond medications
- Stop the trigger — halt the running infusion or transfusion, remove the exposure. It takes seconds and stops the antigen supply feeding the reaction.
- Position: supine with lower extremities elevated — preserves the leaked-out circulation’s remaining volume centrally. Patients must not sit up, stand, or walk until clearly stabilized, even if they feel better: sitting up too soon risks empty ventricle syndrome, a profound fall in blood pressure that can be fatal (Canadian anaphylaxis review, 2024; NHS). Respiratory distress → sitting may optimize breathing (WAO 2020), raising the shoulders or sitting up slowly; pregnant → semi-recumbent on the left side; unconscious → recovery position (WAO 2020).
- High-flow oxygen — preferably 100% via non-rebreather — for all respiratory distress and anyone receiving repeated epinephrine doses (WAO 2020).
- Wide-bore IV access (14–16 gauge) + crystalloid bolus — 1–2 L or 10–20 mL/kg isotonic crystalloid for hypotension (WAO: 20 mL/kg for cardiovascular instability): distributive shock needs volume as well as vasoconstriction.
- Inhaled beta-agonists for wheeze — albuterol (alone or with ipratropium) for bronchospasm; IV magnesium for refractory wheeze. Bronchodilators treat the lower airway only — they do nothing for laryngeal edema or shock.
- Observe at least 4 hours after resolution — longer after severe reactions or multiple epinephrine doses (WAO 2020) — because the biphasic recurrence peaks 8–11 hours out.
Nursing considerations
The RN-specific layer — each action paired with the reason it matters.
How a real nurse thinks
The clinical-judgment loop, worked for a typical presentation — reasoning, not reference.
- 1 Recognize cues
The cues that matter: a first dose of a new IV medication 5 minutes ago (a likely antigen), hives + lip swelling (skin/mucosa), hoarse voice + throat tightness + wheeze (respiratory, with the voice change pointing at the larynx), BP 82/48 against a baseline of 124/76 (both < 90 and > 30% below baseline), SpO₂ 91%, and GI cramping with nausea. The normal temperature and her anxiety are background.
- 2 Analyze cues
This satisfies the WAO criteria twice over: acute skin/mucosal involvement plus respiratory compromise plus hypotension — after a probable allergen. Mechanistically the mast cells have degranulated: vasodilation and capillary leak are emptying her circulation (distributive shock), while leukotrienes and prostaglandin D close her lower airways and laryngeal edema threatens the upper one. The hoarse voice is the most dangerous single cue: the airway is swelling now.
- 3 Prioritize
Epinephrine outranks everything else in the drawer. Half of anaphylaxis deaths occur within the first hour, and epinephrine is the only agent that reverses the mechanism. The diphenhydramine on the PRN list is the trap — its benefit in anaphylaxis is unproven and reaching for it first delays the drug that works. Sequence: stop the antigen → epinephrine IM → position → oxygen → escalate.
- 4 Generate solutions
Stop the antibiotic infusion (seconds, removes the ongoing antigen). Give epinephrine 0.3–0.5 mg IM in the mid-anterolateral thigh per protocol. Lay her supine with legs elevated — no sitting up, however much she wants to. High-flow oxygen for the SpO₂ of 91%. Activate the rapid response and notify the provider: anticipate wide-bore IV access with a 1–2 L crystalloid bolus for the hypotension, repeat epinephrine every 5–15 minutes if symptoms persist, airway support for the hoarse voice, and adjunct antihistamine/steroid after epinephrine. Nothing by mouth while her breathing is compromised.
- 5 Take action
Stop the infusion, inject epinephrine IM in the thigh, position supine with legs raised, apply oxygen, and call the rapid response with SBAR: "First dose of a new IV antibiotic started 5 minutes ago — hives, lip swelling, hoarse voice, wheeze, BP 82/48 from a baseline of 124/76, SpO₂ 91%. Infusion stopped, epinephrine 0.3 mg IM given at 1036, patient supine with legs elevated on oxygen. Requesting immediate evaluation; anticipate fluids and possible repeat epinephrine." Keep her flat — explain why she cannot suddenly sit up even when she feels better.
- 6 Evaluate
Success looks like: BP climbing back toward baseline, the wheeze and hoarseness resolving, SpO₂ recovering on oxygen, hives fading. Symptoms persisting at 5–15 minutes → repeat epinephrine (about a third of patients need a second dose); no response to repeated doses → refractory anaphylaxis, anticipate an ICU-level IV epinephrine infusion. Even a full recovery buys observation, not discharge: at least 4 hours of monitoring, with the biphasic warning delivered before she leaves.
Scenario — you’re the nurse
Work each question before revealing the answer. Rationales explain the wrong options too.
A 34-year-old woman admitted for cellulitis, receiving the first dose of a newly ordered IV antibiotic, started at 1030. Admission vitals this morning: BP 124/76, HR 78. She presses the call light: "My throat feels tight and I feel really strange."
Q1 Select all that apply Five minutes into the first dose of a new IV antibiotic, which findings support a diagnosis of anaphylaxis? Select all that apply. - A. Raised hives spreading across the chest and arms with lip swelling
- B. Hoarse voice, throat tightness, and audible wheeze
- C. BP 82/48 mm Hg (admission baseline 124/76)
- D. Temperature 37.1 °C
- E. Nausea with painful abdominal cramping
Reveal answer & rationale
Q2 Multiple choice Diphenhydramine IV is on the PRN list and closer at hand than the emergency supply. Which medication does the nurse give first? - A. Diphenhydramine IV — it directly blocks the histamine driving the reaction
- B. Epinephrine 0.3–0.5 mg IM in the mid-anterolateral thigh
- C. Methylprednisolone IV to prevent a biphasic reaction
- D. An albuterol nebulizer for the audible wheeze
Reveal answer & rationale
Q3 Put in order Put the nurse’s first four actions in priority order: - A. Activate the rapid response and notify the provider
- B. Stop the antibiotic infusion
- C. Give epinephrine IM in the anterolateral thigh
- D. Position supine with legs elevated and apply high-flow oxygen
Reveal answer & rationale
Q4 Multiple choice Thirty minutes later the patient’s BP is 112/70 and she feels "back to normal." She asks to walk to the bathroom. The best response is: - A. Assist her to stand slowly at the bedside before walking
- B. Allow ambulation with a staff member at her side
- C. Keep her supine with legs elevated and offer a bedpan, explaining that sitting or standing up suddenly is dangerous right now
- D. Raise the head of the bed fully so she can adjust before standing
Reveal answer & rationale
Q5 Select all that apply Before discharge the patient is prescribed an epinephrine auto-injector. Which teaching points does the nurse include? Select all that apply. - A. Press the tip firmly against the mid outer thigh and hold — through clothing if necessary
- B. Get emergency medical care immediately after every injection, even if symptoms improve
- C. Carry two auto-injectors at all times
- D. Take an oral antihistamine first, and inject epinephrine only if it does not help
- E. Return to the ED immediately if symptoms come back hours after this reaction
- F. Store the device in the refrigerator to keep the drug potent
Reveal answer & rationale
Common questions
What causes anaphylaxis & hypersensitivity reactions?
What are the early signs of anaphylaxis & hypersensitivity reactions?
Which findings should a nurse report immediately in anaphylaxis & hypersensitivity reactions?
What are the four types of hypersensitivity reactions?
Why is epinephrine given before antihistamines in anaphylaxis?
What is a biphasic anaphylactic reaction?
Sources
- Anaphylaxis — StatPearls — StatPearls (NCBI Bookshelf)
- Type I Hypersensitivity Reaction — StatPearls — StatPearls (NCBI Bookshelf)
- World Allergy Organization Anaphylaxis Guidance 2020 — World Allergy Organization Journal (PMC)
- Safe and Effective Administration of Vaccines and Epinephrine Autoinjection — StatPearls — StatPearls (NCBI Bookshelf)
- Anaphylaxis (Abrams et al., Allergy Asthma Clin Immunol 2024) — Allergy, Asthma & Clinical Immunology (PMC, CC BY 4.0)
- EpiPen (epinephrine) injection — prescribing information — DailyMed (NLM/FDA)
- Anaphylaxis — NHS. Contains public sector information licensed under the Open Government Licence v3.0 (https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/) — NHS (UK)
- Insect bites and stings — NHS. Contains public sector information licensed under the Open Government Licence v3.0 (https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/) — NHS (UK)
- Anaphylaxis — MedlinePlus — MedlinePlus (NLM)
Reviewed by Hae Suk Lee, RN
Educational summary for nursing students. Scenarios are fictional teaching cases. Always verify against current guidelines and your institution's protocols before acting in practice. Not medical advice.